Cargando…

Cardiovascular disease markers in women with polycystic ovary syndrome with emphasis on asymmetric dimethylarginine and homocysteine

BACKGROUND AND OBJECTIVES: Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Little is known about cardiovascular risk factors in patients with PCOS. We investigated plasma markers of cardiovascular disease in Saudi women...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamadin, Ahmed M., Habib, Fawzia A., Al-Saggaf, Abdulrahman A.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931778/ https://www.ncbi.nlm.nih.gov/pubmed/20622344 http://dx.doi.org/10.4103/0256-4947.65255

Ejemplares similares

Assessment of asymmetric dimethylarginine and homocysteine in epileptic children receiving antiepileptic drugs
por: Mahmoud, Asmaa A., et al.
Publicado: (2022)

Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
por: Tommasi, S., et al.
Publicado: (2017)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

Homocysteine is an indicator of arterial stiffness in Chinese women with polycystic ovary syndrome
por: Wu, Xia, et al.
Publicado: (2021)

Homocysteine and C-reactive Protein Levels in Women with Polycystic Ovary Syndrome
por: Gözüküçük, Murat, et al.
Publicado: (2021)

Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B(12), and Homocysteine Levels in Individuals with Pulmonary Embolism
por: Altuntaş, Murat, et al.
Publicado: (2011)

Effect of Blood Homocysteine on the Outcome of Artificial Insemination in Women with Polycystic Ovary Syndrome
por: Cao, Jing, et al.
Publicado: (2022)

The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome
por: Dawson, Alison J., et al.
Publicado: (2019)

Effects of Metformin Treatment on Homocysteine Levels and Metabolic Parameters of Women With Polycystic Ovary Syndrome
por: Riahinejad, Soheila, et al.
Publicado: (2015)

Retracted: Effect of Blood Homocysteine on the Outcome of Artificial Insemination in Women with Polycystic Ovary Syndrome
por: International, BioMed Research
Publicado: (2023)

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
por: Sibal, Latika, et al.
Publicado: (2010)

Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease
por: Franceschelli, Sara, et al.
Publicado: (2013)

Asymmetric Dimethylarginine in COPD Exacerbation
por: Ozkarafakili, Mufide Arzu, et al.
Publicado: (2022)

Asymmetric Dimethylarginine as a Surrogate Marker of Endothelial Dysfunction and Cardiovascular Risk in Patients with Systemic Rheumatic Diseases
por: Dimitroulas, Theodoros, et al.
Publicado: (2012)

Inflammatory Markers in Women with Polycystic Ovary Syndrome
por: Rudnicka, E., et al.
Publicado: (2020)

A comparison of maternal serum levels of endothelial nitric oxide synthase, asymmetric dimethylarginine, and homocysteine in normal and preeclamptic pregnancies
por: Laskowska, Marzena, et al.
Publicado: (2013)

Asymmetric Dimethylarginin (ADMA) as a Marker of Endothelial Dysfunction in Primary Aldosteronism
por: Matrozova, Joanna, et al.
Publicado: (2016)

Evaluation of asymmetric dimethylarginine as an inflammatory and prognostic marker in dogs with acute pancreatitis
por: Gori, Eleonora, et al.
Publicado: (2020)

Risk of Cardiovascular Diseases in Diabetes Mellitus and Serum Concentration of Asymmetrical Dimethylarginine
por: Jawalekar, Seema L., et al.
Publicado: (2013)

Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013)

Renal asymmetric dimethylarginine inhibits fibrosis
por: Wu, Ming, et al.
Publicado: (2020)

Effects of Metformin With or Without Supplementation With Folate on Homocysteine Levels and Vascular Endothelium of Women With Polycystic Ovary Syndrome
por: Palomba, Stefano, et al.
Publicado: (2010)

Association between asymmetric dimethylarginine and sarcopenia in community-dwelling older women
por: Yokoro, Miyuki, et al.
Publicado: (2023)

Asymmetric dimethylarginine is not a marker of arterial damage in children with glomerular kidney diseases
por: SKRZYPCZYK, PIOTR, et al.
Publicado: (2020)

Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients
por: Stanisavljevic, Natasa, et al.
Publicado: (2022)

Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease
por: Blagojevic, Iva Perovic, et al.
Publicado: (2017)

Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls
por: Witchel, Selma Feldman, et al.
Publicado: (2019)

Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease
por: Jud, Philipp, et al.
Publicado: (2018)

Asymmetric Dimethylarginine and Cardiovascular Risk: Systematic Review and Meta-Analysis of 22 Prospective Studies
por: Willeit, Peter, et al.
Publicado: (2015)

Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
por: Aldámiz-Echevarría, Luis, et al.
Publicado: (2012)

Arginine/Asymmetric Dimethylarginine Ratio in Colorectal Surgery
por: Ragina, Neli, et al.
Publicado: (2017)

Cadmium-induced endothelial dysfunction mediated by asymmetric dimethylarginine
por: Al-Naemi, Hamda A., et al.
Publicado: (2020)

L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis
por: Pascale, Valerio, et al.
Publicado: (2013)

Increased symmetric dimethylarginine, but not asymmetric dimethylarginine, concentrations are associated with transient myocardial ischemia and predict outcome
por: Szabo, Zsuzsanna, et al.
Publicado: (2020)

Study of early atherosclerotic markers in women with polycystic ovary syndrome
por: Karoli, Ritu, et al.
Publicado: (2012)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies
por: Schlesinger, Sabrina, et al.
Publicado: (2016)

Diurnal Variation of L-Arginine and the Cardiovascular Risk Markers Asymmetric and Symmetric Dimethylarginine and Homoarginine in Rotating Night Shift Workers and Controls
por: Hannemann, Juliane, et al.
Publicado: (2023)

Resolution and quantification of arginine, monomethylarginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma using HPLC with internal calibration
por: Alkaitis, Matthew S., et al.
Publicado: (2015)

Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
por: Lee, Tzong-Shyuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bnl5uhccvbpkt7r184jashec7d